Keyphrases
Single-center Experience
100%
Orthotopic Heart Transplantation
100%
Antibody-mediated Rejection
100%
Angiotensin II Type 1 Receptor Antibody
100%
Angiotensin Receptor Blockers
42%
Graft Dysfunction
42%
Antibody Titer
28%
Clinical Treatment
14%
Clinical Outcomes
14%
Patient Outcomes
14%
Angiotensin II Type 1 Receptor (AT1R)
14%
Pathologic
14%
Left Ventricular Ejection Fraction
14%
Optimal Treatment
14%
Endothelium
14%
Plasmapheresis
14%
Endocardium
14%
Rituximab
14%
Graft Function
14%
Symptom Improvement
14%
Endomyocardial Biopsy
14%
Treatment Modalities
14%
Antibody Level
14%
Left Ventricular Assist Device
14%
Single-center Study
14%
Acute Cellular Rejection
14%
Minimal Change
14%
Intravenous Immunoglobulin (IVIg)
14%
CD68
14%
Rejection Treatment
14%
Orthotopic Heart Transplant Recipient
14%
ATR1
14%
Medicine and Dentistry
Heart Graft
100%
Angiotensin II
100%
Antibody Mediated Rejection
100%
Receptor Antibody
100%
Angiotensin Receptor Antagonist
42%
Graft Dysfunction
42%
Acute Graft Rejection
14%
Heart Left Ventricle Ejection Fraction
14%
Plasmapheresis
14%
Rituximab
14%
Endocardium
14%
Heart Muscle Biopsy
14%
Left Ventricular Assist Device
14%
Chlordane
14%
Complement Component C4d
14%